ELV vs PYXS · P/E 18, rev $199.13B vs rev $2.8M
Elevance Health Inc (ELV) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the ELV and PYXS stock pages for the full models.
Not investment advice.